Core Viewpoint - Danone and Nestlé are recalling multiple batches of infant formula due to concerns about potential contamination with a dangerous toxin, leading to a significant drop in Danone's stock price [1][2]. Group 1: Stock Performance - Danone's stock fell by 5.9% on Monday, continuing a decline of over 10% from the previous week [2][7]. - The current stock price is €64, marking a one-year low, down from €80 in November of the previous year [8]. Group 2: Recall Details - The recall involves a "very small number of specific batches" of infant formula, initiated after similar actions by Nestlé and Lactalis [1][6]. - The products are being recalled in Singapore and Europe due to potential contamination with Bacillus cereus toxin, which can cause nausea and vomiting [2][7]. - The Irish Food Safety Authority has requested Danone to recall certain batches produced at its Irish facility, which supplies multiple European countries [8]. Group 3: Financial Impact - Jefferies analyst David Hayes noted that the sales from the recalled products are estimated to be less than €40 million [8]. - Bernstein analyst Callum Elliott estimated that the direct impact on Danone's revenue from the recall will be less than €50 million [9]. - If Danone's core brand, Aptamil, which contributes 30% of the company's profits, is affected, it could lead to reputational damage [9]. Group 4: Industry Context - The recall is part of a broader issue affecting the industry, with Nestlé's global recall potentially costing up to €1.6 billion, equivalent to 1.7% of its sales [3][4]. - Nestlé has apologized for the recall and stated that it does not expect a significant financial impact [4].